Cencora, Inc. $COR Stock Position Lifted by Mather Group LLC.

Mather Group LLC. lifted its position in Cencora, Inc. (NYSE:COR) by 119.0% during the 3rd quarter, Holdings Channel reports. The firm owned 6,227 shares of the company’s stock after acquiring an additional 3,383 shares during the period. Mather Group LLC.’s holdings in Cencora were worth $1,870,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in COR. Steph & Co. raised its holdings in Cencora by 23.5% during the 1st quarter. Steph & Co. now owns 168 shares of the company’s stock valued at $53,000 after buying an additional 32 shares during the last quarter. Cornerstone Wealth Group LLC grew its holdings in Cencora by 1.6% in the 1st quarter. Cornerstone Wealth Group LLC now owns 2,434 shares of the company’s stock worth $760,000 after acquiring an additional 38 shares during the last quarter. OLD National Bancorp IN grew its holdings in Cencora by 0.4% in the 1st quarter. OLD National Bancorp IN now owns 9,964 shares of the company’s stock worth $3,130,000 after acquiring an additional 40 shares during the last quarter. Staley Capital Advisers Inc. grew its holdings in Cencora by 0.7% in the 1st quarter. Staley Capital Advisers Inc. now owns 6,127 shares of the company’s stock worth $1,925,000 after acquiring an additional 40 shares during the last quarter. Finally, Elmwood Wealth Management Inc. increased its position in shares of Cencora by 0.9% in the second quarter. Elmwood Wealth Management Inc. now owns 4,314 shares of the company’s stock valued at $1,221,000 after acquiring an additional 40 shares during the period. 97.52% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Cencora

In other Cencora news, EVP Elizabeth Campbell sold 11,300 shares of the firm’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $324.12, for a total value of $3,662,556.00. Following the completion of the sale, the executive vice president directly owned 19,455 shares in the company, valued at $6,305,754.60. This trade represents a 36.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.38% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

COR has been the subject of several recent analyst reports. Argus lowered their price objective on shares of Cencora to $340.00 and set a “buy” rating for the company in a research note on Tuesday, June 23rd. Weiss Ratings upgraded shares of Cencora from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday, October 6th. Citigroup reissued a “buy” rating on shares of Cencora in a research note on Thursday, August 6th. Evercore restated an “outperform” rating and set a $350.00 price target (up from $330.00) on shares of Cencora in a report on Thursday, August 6th. Finally, Wells Fargo & Company boosted their price target on Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a report on Tuesday, August 11th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $363.81.

Cencora Trading Down 0.3%

NYSE COR traded down $0.87 during trading on Friday, hitting $340.54. The company had a trading volume of 1,978,868 shares, compared to its average volume of 1,282,490. The company has a current ratio of 0.93, a quick ratio of 0.58 and a debt-to-equity ratio of 3.53. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54. The company has a market cap of $64.99 billion, a price-to-earnings ratio of 25.30, a price-to-earnings-growth ratio of 1.75 and a beta of 0.58. The company’s fifty day moving average is $320.38 and its 200-day moving average is $303.34.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, August 5th. The company reported $4.48 EPS for the quarter, topping the consensus estimate of $4.35 by $0.13. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The firm had revenue of $84.75 billion during the quarter, compared to analysts’ expectations of $84.31 billion. During the same period last year, the company posted $4.00 EPS. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. On average, sell-side analysts predict that Cencora, Inc. will post 17.87 earnings per share for the current year.

Cencora Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Friday, August 14th. Cencora’s dividend payout ratio is presently 17.83%.

About Cencora

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical solutions company that sources, distributes and supports the delivery of medicines and healthcare products. The company serves pharmaceutical manufacturers, healthcare providers, pharmacies and animal-health customers through its supply-chain and commercialization services.

Its activities include pharmaceutical and specialty-product distribution, manufacturer services, specialty logistics, clinical-trial support, patient-support programs and other services designed to help bring medicines to market and improve access to treatment.